Top Markets
Coin of the day
Pardes Biosciences, Inc. Pardes Biosciences, Inc.

Pardes Biosciences, Inc.

PRDS
Rang in Aktien #20774
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated... Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to identifying, developing, and marketing groundbreaking treatments. The company's core objective is to improve outcomes for patients battling life-threatening illnesses. Its primary investigational therapy, PBI-0451, is currently progressing through clinical development with the aim of both treating and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and their related health issues. Established in 2020, Pardes Biosciences maintains its corporate headquarters in Carlsbad, California.
Aktienkurs
$2.16
Zuletzt synchronisiert: 2023-09-08
Marktkapitalisierung
$122.36M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Pardes Biosciences, Inc. (PRDS)

Kategorie

Kursverlauf für Pardes Biosciences, Inc. (PRDS)
Höchster Schlusskurs: $2.16 am 2023-09-01

Niedrigster Schlusskurs: $10.79 am 2021-02-01
Kursverlauf der Aktie von Pardes Biosciences, Inc. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2023 73.46%
2022 -89.54%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.76 -14.85%
AU
$770.19 8.98%
CH